VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,839,005 | -82.2% | 105,500 | -80.1% | 0.10% | -82.9% |
| Q2 2023 | $15,947,099 | +337.3% | 529,628 | +369.8% | 0.57% | +346.9% |
| Q1 2023 | $3,646,945 | -54.0% | 112,734 | -59.2% | 0.13% | -64.9% |
| Q4 2022 | $7,926,840 | +8.4% | 276,582 | -31.0% | 0.36% | +9.9% |
| Q3 2022 | $7,312,000 | -24.1% | 400,802 | +13.9% | 0.33% | -2.1% |
| Q2 2022 | $9,637,000 | -26.6% | 352,000 | -14.2% | 0.34% | +73.8% |
| Q4 2021 | $13,134,000 | +4.7% | 410,060 | -3.7% | 0.20% | -36.5% |
| Q3 2021 | $12,542,000 | -44.4% | 425,601 | -35.9% | 0.31% | -24.8% |
| Q2 2021 | $22,572,000 | +21.6% | 664,304 | +16.3% | 0.41% | +4.1% |
| Q1 2021 | $18,566,000 | -18.4% | 571,208 | -9.6% | 0.39% | -34.2% |
| Q4 2020 | $22,755,000 | +1.0% | 631,736 | +9.8% | 0.60% | +4.6% |
| Q3 2020 | $22,523,000 | -7.0% | 575,162 | -12.8% | 0.57% | +35.7% |
| Q2 2020 | $24,206,000 | +7733.7% | 659,929 | +4818.6% | 0.42% | +2370.6% |
| Q1 2020 | $309,000 | -99.4% | 13,417 | -99.2% | 0.02% | -97.7% |
| Q4 2019 | $49,591,000 | +6.5% | 1,693,642 | -2.9% | 0.74% | -22.9% |
| Q3 2019 | $46,579,000 | -11.0% | 1,743,921 | -14.8% | 0.97% | +8.8% |
| Q2 2019 | $52,345,000 | +771.5% | 2,047,875 | +664.4% | 0.89% | +508.2% |
| Q1 2019 | $6,006,000 | -80.5% | 267,900 | -81.6% | 0.15% | -84.5% |
| Q4 2018 | $30,766,000 | -46.8% | 1,458,800 | -53.3% | 0.94% | -10.6% |
| Q3 2018 | $57,860,000 | +637.4% | 3,124,176 | +788.3% | 1.05% | +635.7% |
| Q2 2018 | $7,847,000 | +47.0% | 351,706 | +44.8% | 0.14% | +70.2% |
| Q1 2018 | $5,338,000 | +1048.0% | 242,810 | +1114.0% | 0.08% | +1300.0% |
| Q4 2017 | $465,000 | -94.0% | 20,000 | -94.0% | 0.01% | -94.3% |
| Q3 2017 | $7,717,000 | -28.2% | 336,112 | -31.0% | 0.10% | -17.3% |
| Q2 2017 | $10,749,000 | -78.4% | 486,800 | -77.7% | 0.13% | -78.7% |
| Q1 2017 | $49,746,000 | +13.6% | 2,180,891 | +4.2% | 0.60% | +38.9% |
| Q4 2016 | $43,795,000 | +6.5% | 2,093,494 | +34.6% | 0.43% | -16.7% |
| Q3 2016 | $41,122,000 | +106.4% | 1,555,898 | +116.4% | 0.52% | +136.2% |
| Q2 2016 | $19,919,000 | – | 719,100 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |